Tianeptine Market

1 Study Coverage
    1.1 Tianeptine Product Introduction
    1.2 Market by Type
        1.2.1 Global Tianeptine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Patent
        1.2.3 Generic
    1.3 Market by Application
        1.3.1 Global Tianeptine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Depression and Anxiety
        1.3.3 Irritable Bowel Syndrome
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Tianeptine Sales Estimates and Forecasts 2017-2028
    2.2 Global Tianeptine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Tianeptine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Tianeptine Sales by Region
        2.4.1 Global Tianeptine Sales by Region (2017-2022)
        2.4.2 Global Sales Tianeptine by Region (2023-2028)
    2.5 Global Tianeptine Revenue by Region
        2.5.1 Global Tianeptine Revenue by Region (2017-2022)
        2.5.2 Global Tianeptine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Tianeptine Sales by Manufacturers
        3.1.1 Global Top Tianeptine Manufacturers by Sales (2017-2022)
        3.1.2 Global Tianeptine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tianeptine in 2021
    3.2 Global Tianeptine Revenue by Manufacturers
        3.2.1 Global Tianeptine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Tianeptine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Tianeptine Revenue in 2021
    3.3 Global Tianeptine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Tianeptine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Tianeptine Sales by Type
        4.1.1 Global Tianeptine Historical Sales by Type (2017-2022)
        4.1.2 Global Tianeptine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Tianeptine Sales Market Share by Type (2017-2028)
    4.2 Global Tianeptine Revenue by Type
        4.2.1 Global Tianeptine Historical Revenue by Type (2017-2022)
        4.2.2 Global Tianeptine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Tianeptine Revenue Market Share by Type (2017-2028)
    4.3 Global Tianeptine Price by Type
        4.3.1 Global Tianeptine Price by Type (2017-2022)
        4.3.2 Global Tianeptine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Tianeptine Sales by Application
        5.1.1 Global Tianeptine Historical Sales by Application (2017-2022)
        5.1.2 Global Tianeptine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Tianeptine Sales Market Share by Application (2017-2028)
    5.2 Global Tianeptine Revenue by Application
        5.2.1 Global Tianeptine Historical Revenue by Application (2017-2022)
        5.2.2 Global Tianeptine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Tianeptine Revenue Market Share by Application (2017-2028)
    5.3 Global Tianeptine Price by Application
        5.3.1 Global Tianeptine Price by Application (2017-2022)
        5.3.2 Global Tianeptine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Tianeptine Market Size by Type
        6.1.1 North America Tianeptine Sales by Type (2017-2028)
        6.1.2 North America Tianeptine Revenue by Type (2017-2028)
    6.2 North America Tianeptine Market Size by Application
        6.2.1 North America Tianeptine Sales by Application (2017-2028)
        6.2.2 North America Tianeptine Revenue by Application (2017-2028)
    6.3 North America Tianeptine Market Size by Country
        6.3.1 North America Tianeptine Sales by Country (2017-2028)
        6.3.2 North America Tianeptine Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Tianeptine Market Size by Type
        7.1.1 Europe Tianeptine Sales by Type (2017-2028)
        7.1.2 Europe Tianeptine Revenue by Type (2017-2028)
    7.2 Europe Tianeptine Market Size by Application
        7.2.1 Europe Tianeptine Sales by Application (2017-2028)
        7.2.2 Europe Tianeptine Revenue by Application (2017-2028)
    7.3 Europe Tianeptine Market Size by Country
        7.3.1 Europe Tianeptine Sales by Country (2017-2028)
        7.3.2 Europe Tianeptine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Tianeptine Market Size by Type
        8.1.1 Asia Pacific Tianeptine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Tianeptine Revenue by Type (2017-2028)
    8.2 Asia Pacific Tianeptine Market Size by Application
        8.2.1 Asia Pacific Tianeptine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Tianeptine Revenue by Application (2017-2028)
    8.3 Asia Pacific Tianeptine Market Size by Region
        8.3.1 Asia Pacific Tianeptine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Tianeptine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Tianeptine Market Size by Type
        9.1.1 Latin America Tianeptine Sales by Type (2017-2028)
        9.1.2 Latin America Tianeptine Revenue by Type (2017-2028)
    9.2 Latin America Tianeptine Market Size by Application
        9.2.1 Latin America Tianeptine Sales by Application (2017-2028)
        9.2.2 Latin America Tianeptine Revenue by Application (2017-2028)
    9.3 Latin America Tianeptine Market Size by Country
        9.3.1 Latin America Tianeptine Sales by Country (2017-2028)
        9.3.2 Latin America Tianeptine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Tianeptine Market Size by Type
        10.1.1 Middle East and Africa Tianeptine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Tianeptine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Tianeptine Market Size by Application
        10.2.1 Middle East and Africa Tianeptine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Tianeptine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Tianeptine Market Size by Country
        10.3.1 Middle East and Africa Tianeptine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Tianeptine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Servier
        11.1.1 Servier Corporation Information
        11.1.2 Servier Overview
        11.1.3 Servier Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Servier Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Servier Recent Developments
    11.2 Lupin Limited
        11.2.1 Lupin Limited Corporation Information
        11.2.2 Lupin Limited Overview
        11.2.3 Lupin Limited Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Lupin Limited Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Lupin Limited Recent Developments
    11.3 PharmaS
        11.3.1 PharmaS Corporation Information
        11.3.2 PharmaS Overview
        11.3.3 PharmaS Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 PharmaS Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 PharmaS Recent Developments
    11.4 Antibiotice
        11.4.1 Antibiotice Corporation Information
        11.4.2 Antibiotice Overview
        11.4.3 Antibiotice Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Antibiotice Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Antibiotice Recent Developments
    11.5 Serdia Pharmaceuticals
        11.5.1 Serdia Pharmaceuticals Corporation Information
        11.5.2 Serdia Pharmaceuticals Overview
        11.5.3 Serdia Pharmaceuticals Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Serdia Pharmaceuticals Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Serdia Pharmaceuticals Recent Developments
    11.6 Alvogen
        11.6.1 Alvogen Corporation Information
        11.6.2 Alvogen Overview
        11.6.3 Alvogen Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Alvogen Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Alvogen Recent Developments
    11.7 Bausch Health
        11.7.1 Bausch Health Corporation Information
        11.7.2 Bausch Health Overview
        11.7.3 Bausch Health Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Bausch Health Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Bausch Health Recent Developments
    11.8 Genefar B.V.
        11.8.1 Genefar B.V. Corporation Information
        11.8.2 Genefar B.V. Overview
        11.8.3 Genefar B.V. Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Genefar B.V. Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Genefar B.V. Recent Developments
    11.9 Arena Pharmaceuticals
        11.9.1 Arena Pharmaceuticals Corporation Information
        11.9.2 Arena Pharmaceuticals Overview
        11.9.3 Arena Pharmaceuticals Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Arena Pharmaceuticals Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Arena Pharmaceuticals Recent Developments
    11.10 Glenmark
        11.10.1 Glenmark Corporation Information
        11.10.2 Glenmark Overview
        11.10.3 Glenmark Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Glenmark Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Glenmark Recent Developments
    11.11 Novartis
        11.11.1 Novartis Corporation Information
        11.11.2 Novartis Overview
        11.11.3 Novartis Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Novartis Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Novartis Recent Developments
    11.12 Dongwha Pharm
        11.12.1 Dongwha Pharm Corporation Information
        11.12.2 Dongwha Pharm Overview
        11.12.3 Dongwha Pharm Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Dongwha Pharm Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Dongwha Pharm Recent Developments
    11.13 Liconsa SA
        11.13.1 Liconsa SA Corporation Information
        11.13.2 Liconsa SA Overview
        11.13.3 Liconsa SA Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Liconsa SA Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Liconsa SA Recent Developments
    11.14 Mylan
        11.14.1 Mylan Corporation Information
        11.14.2 Mylan Overview
        11.14.3 Mylan Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Mylan Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Mylan Recent Developments
    11.15 Adamed
        11.15.1 Adamed Corporation Information
        11.15.2 Adamed Overview
        11.15.3 Adamed Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Adamed Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Adamed Recent Developments
    11.16 Neuraxpharm Arzneimittel
        11.16.1 Neuraxpharm Arzneimittel Corporation Information
        11.16.2 Neuraxpharm Arzneimittel Overview
        11.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Neuraxpharm Arzneimittel Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Neuraxpharm Arzneimittel Recent Developments
    11.17 Grupo Insud
        11.17.1 Grupo Insud Corporation Information
        11.17.2 Grupo Insud Overview
        11.17.3 Grupo Insud Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Grupo Insud Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Grupo Insud Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Tianeptine Industry Chain Analysis
    12.2 Tianeptine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Tianeptine Production Mode & Process
    12.4 Tianeptine Sales and Marketing
        12.4.1 Tianeptine Sales Channels
        12.4.2 Tianeptine Distributors
    12.5 Tianeptine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Tianeptine Industry Trends
    13.2 Tianeptine Market Drivers
    13.3 Tianeptine Market Challenges
    13.4 Tianeptine Market Restraints
14 Key Findings in The Global Tianeptine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Tianeptine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Patent
    Table 3. Major Manufacturers of Generic
    Table 4. Global Tianeptine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Tianeptine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Tianeptine Sales by Region (2017-2022) & (K Units)
    Table 7. Global Tianeptine Sales Market Share by Region (2017-2022)
    Table 8. Global Tianeptine Sales by Region (2023-2028) & (K Units)
    Table 9. Global Tianeptine Sales Market Share by Region (2023-2028)
    Table 10. Global Tianeptine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Tianeptine Revenue Market Share by Region (2017-2022)
    Table 12. Global Tianeptine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Tianeptine Revenue Market Share by Region (2023-2028)
    Table 14. Global Tianeptine Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Tianeptine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Tianeptine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Tianeptine Revenue Share by Manufacturers (2017-2022)
    Table 18. Tianeptine Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Tianeptine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Tianeptine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tianeptine as of 2021)
    Table 21. Tianeptine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Tianeptine Product Offered
    Table 23. Date of Manufacturers Enter into Tianeptine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Tianeptine Sales by Type (2017-2022) & (K Units)
    Table 26. Global Tianeptine Sales by Type (2023-2028) & (K Units)
    Table 27. Global Tianeptine Sales Share by Type (2017-2022)
    Table 28. Global Tianeptine Sales Share by Type (2023-2028)
    Table 29. Global Tianeptine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Tianeptine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Tianeptine Revenue Share by Type (2017-2022)
    Table 32. Global Tianeptine Revenue Share by Type (2023-2028)
    Table 33. Tianeptine Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Tianeptine Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Tianeptine Sales by Application (2017-2022) & (K Units)
    Table 36. Global Tianeptine Sales by Application (2023-2028) & (K Units)
    Table 37. Global Tianeptine Sales Share by Application (2017-2022)
    Table 38. Global Tianeptine Sales Share by Application (2023-2028)
    Table 39. Global Tianeptine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Tianeptine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Tianeptine Revenue Share by Application (2017-2022)
    Table 42. Global Tianeptine Revenue Share by Application (2023-2028)
    Table 43. Tianeptine Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Tianeptine Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Tianeptine Sales by Type (2017-2022) & (K Units)
    Table 46. North America Tianeptine Sales by Type (2023-2028) & (K Units)
    Table 47. North America Tianeptine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Tianeptine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Tianeptine Sales by Application (2017-2022) & (K Units)
    Table 50. North America Tianeptine Sales by Application (2023-2028) & (K Units)
    Table 51. North America Tianeptine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Tianeptine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Tianeptine Sales by Country (2017-2022) & (K Units)
    Table 54. North America Tianeptine Sales by Country (2023-2028) & (K Units)
    Table 55. North America Tianeptine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Tianeptine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Tianeptine Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Tianeptine Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Tianeptine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Tianeptine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Tianeptine Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Tianeptine Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Tianeptine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Tianeptine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Tianeptine Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Tianeptine Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Tianeptine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Tianeptine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Tianeptine Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Tianeptine Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Tianeptine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Tianeptine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Tianeptine Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Tianeptine Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Tianeptine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Tianeptine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Tianeptine Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Tianeptine Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Tianeptine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Tianeptine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Tianeptine Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Tianeptine Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Tianeptine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Tianeptine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Tianeptine Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Tianeptine Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Tianeptine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Tianeptine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Tianeptine Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Tianeptine Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Tianeptine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Tianeptine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Tianeptine Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Tianeptine Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Tianeptine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Tianeptine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Tianeptine Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Tianeptine Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Tianeptine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Tianeptine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Tianeptine Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Tianeptine Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Tianeptine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Tianeptine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Servier Corporation Information
    Table 106. Servier Description and Major Businesses
    Table 107. Servier Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Servier Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Servier Recent Developments
    Table 110. Lupin Limited Corporation Information
    Table 111. Lupin Limited Description and Major Businesses
    Table 112. Lupin Limited Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Lupin Limited Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Lupin Limited Recent Developments
    Table 115. PharmaS Corporation Information
    Table 116. PharmaS Description and Major Businesses
    Table 117. PharmaS Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. PharmaS Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. PharmaS Recent Developments
    Table 120. Antibiotice Corporation Information
    Table 121. Antibiotice Description and Major Businesses
    Table 122. Antibiotice Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Antibiotice Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Antibiotice Recent Developments
    Table 125. Serdia Pharmaceuticals Corporation Information
    Table 126. Serdia Pharmaceuticals Description and Major Businesses
    Table 127. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Serdia Pharmaceuticals Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Serdia Pharmaceuticals Recent Developments
    Table 130. Alvogen Corporation Information
    Table 131. Alvogen Description and Major Businesses
    Table 132. Alvogen Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Alvogen Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Alvogen Recent Developments
    Table 135. Bausch Health Corporation Information
    Table 136. Bausch Health Description and Major Businesses
    Table 137. Bausch Health Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Bausch Health Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Bausch Health Recent Developments
    Table 140. Genefar B.V. Corporation Information
    Table 141. Genefar B.V. Description and Major Businesses
    Table 142. Genefar B.V. Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Genefar B.V. Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Genefar B.V. Recent Developments
    Table 145. Arena Pharmaceuticals Corporation Information
    Table 146. Arena Pharmaceuticals Description and Major Businesses
    Table 147. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Arena Pharmaceuticals Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Arena Pharmaceuticals Recent Developments
    Table 150. Glenmark Corporation Information
    Table 151. Glenmark Description and Major Businesses
    Table 152. Glenmark Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Glenmark Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Glenmark Recent Developments
    Table 155. Novartis Corporation Information
    Table 156. Novartis Description and Major Businesses
    Table 157. Novartis Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Novartis Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Novartis Recent Developments
    Table 160. Dongwha Pharm Corporation Information
    Table 161. Dongwha Pharm Description and Major Businesses
    Table 162. Dongwha Pharm Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Dongwha Pharm Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Dongwha Pharm Recent Developments
    Table 165. Liconsa SA Corporation Information
    Table 166. Liconsa SA Description and Major Businesses
    Table 167. Liconsa SA Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Liconsa SA Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Liconsa SA Recent Developments
    Table 170. Mylan Corporation Information
    Table 171. Mylan Description and Major Businesses
    Table 172. Mylan Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 173. Mylan Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Mylan Recent Developments
    Table 175. Adamed Corporation Information
    Table 176. Adamed Description and Major Businesses
    Table 177. Adamed Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 178. Adamed Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Adamed Recent Developments
    Table 180. Neuraxpharm Arzneimittel Corporation Information
    Table 181. Neuraxpharm Arzneimittel Description and Major Businesses
    Table 182. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 183. Neuraxpharm Arzneimittel Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. Neuraxpharm Arzneimittel Recent Developments
    Table 185. Grupo Insud Corporation Information
    Table 186. Grupo Insud Description and Major Businesses
    Table 187. Grupo Insud Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 188. Grupo Insud Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Grupo Insud Recent Developments
    Table 190. Key Raw Materials Lists
    Table 191. Raw Materials Key Suppliers Lists
    Table 192. Tianeptine Distributors List
    Table 193. Tianeptine Customers List
    Table 194. Tianeptine Market Trends
    Table 195. Tianeptine Market Drivers
    Table 196. Tianeptine Market Challenges
    Table 197. Tianeptine Market Restraints
    Table 198. Research Programs/Design for This Report
    Table 199. Key Data Information from Secondary Sources
    Table 200. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tianeptine Product Picture
    Figure 3. Global Tianeptine Market Share by Type in 2021 & 2028
    Figure 3. Patent Product Picture
    Figure 4. Generic Product Picture
    Figure 5. Global Tianeptine Market Share by Application in 2021 & 2028
    Figure 6. Depression and Anxiety
    Figure 7. Irritable Bowel Syndrome
    Figure 8. Tianeptine Report Years Considered
    Figure 9. Global Tianeptine Sales 2017-2028 (K Units)
    Figure 10. Global Tianeptine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Tianeptine Revenue 2017-2028 (US$ Million)
    Figure 12. Global Tianeptine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Tianeptine Sales Market Share by Region (2017-2022)
    Figure 14. Global Tianeptine Sales Market Share by Region (2023-2028)
    Figure 15. North America Tianeptine Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Tianeptine Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Tianeptine Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Tianeptine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Tianeptine Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Tianeptine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Tianeptine Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Tianeptine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Tianeptine Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Tianeptine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Tianeptine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Tianeptine in the World: Market Share by Tianeptine Revenue in 2021
    Figure 27. Global Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Tianeptine Sales Market Share by Type (2017-2028)
    Figure 29. Global Tianeptine Revenue Market Share by Type (2017-2028)
    Figure 30. Global Tianeptine Sales Market Share by Application (2017-2028)
    Figure 31. Global Tianeptine Revenue Market Share by Application (2017-2028)
    Figure 32. North America Tianeptine Sales Market Share by Type (2017-2028)
    Figure 33. North America Tianeptine Revenue Market Share by Type (2017-2028)
    Figure 34. North America Tianeptine Sales Market Share by Application (2017-2028)
    Figure 35. North America Tianeptine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Tianeptine Sales Share by Country (2017-2028)
    Figure 37. North America Tianeptine Revenue Share by Country (2017-2028)
    Figure 38. United States Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Tianeptine Sales Market Share by Type (2017-2028)
    Figure 41. Europe Tianeptine Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Tianeptine Sales Market Share by Application (2017-2028)
    Figure 43. Europe Tianeptine Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Tianeptine Sales Share by Country (2017-2028)
    Figure 45. Europe Tianeptine Revenue Share by Country (2017-2028)
    Figure 46. Germany Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 47. France Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Tianeptine Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Tianeptine Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Tianeptine Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Tianeptine Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Tianeptine Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Tianeptine Revenue Share by Region (2017-2028)
    Figure 57. China Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 60. India Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Tianeptine Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Tianeptine Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Tianeptine Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Tianeptine Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Tianeptine Sales Share by Country (2017-2028)
    Figure 71. Latin America Tianeptine Revenue Share by Country (2017-2028)
    Figure 72. Mexico Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Tianeptine Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Tianeptine Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Tianeptine Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Tianeptine Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Tianeptine Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Tianeptine Revenue Share by Country (2017-2028)
    Figure 81. Turkey Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Tianeptine Revenue (2017-2028) & (US$ Million)
    Figure 84. Tianeptine Value Chain
    Figure 85. Tianeptine Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed